Results 111 to 120 of about 1,190,674 (269)

Microsoft Kinect-based differences in lower limb kinematics and temporal characteristics of sit to walking phase of modified TUG test between men with and without Parkinson's disease [PDF]

, 2017
http://www.ester.ee/record ...
Kähär, Hedi
core  

Towards an Architecture to Guarantee Both Data Privacy and Utility in the First Phases of Digital Clinical Trials

Sensors, 2018
In the era of the Internet of Things (IoT), drug developers can potentially access a wealth of real-world, participant-generated data that enable better insights and streamlined clinical trial processes.
Fabio Angeletti, Ioannis Chatzigiannakis, Andrea Vitaletti   +2 more
doaj   +1 more source

Phase I study of MEN-10755, a new anthracycline in patients with solid tumours: a report from the European Organization for Research and Treatment of Cancer, Early Clinical Studies Group [PDF]

, 2002
D. Schrijvers, A.M.E. Bos, J. Dyck, Elisabeth G.E. de Vries, J. Wanders, M. Roelvink, P. Fumoleau, S. Bortini, Jan B. Vermorken   +8 more
openalex   +1 more source

Maintaining physical activity in cardiac rehabilitation [PDF]

, 2006
This chapter describes an intervention that has been used to encourage individuals to remain regularly physically active in exercise-based CR in phases III and IV.The principles of this intervention are also appropriate for allphases of CR.This ...
Hughes, Adrienne, Mutrie, Nanette
core  

Lingual articulation in children with developmental speech disorders [PDF]

, 1998
This thesis presents thirteen research papers published between 1987-97, and a summary and discussion of their contribution to the field of developmental speech disorders.
Gibbon, Fiona E.
core  

Premenstrual dysphoric disorder—an undervalued diagnosis? Preliminary results of a prospective study on Hungarian women

European Psychiatry
Introduction The premenstrual dysphoric disorder (PMDD) is a new distinct diagnostic entity in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
B. Pataki, B. L. Kiss, I. Juhász, S. Kálmán, I. Kovács   +4 more
doaj   +1 more source

Overcoming the translational roadblocks: a cancer care and research model

Clinical and Translational Medicine, 2014
There are many challenges to the process of translating the knowledge gained in the laboratory into new clinical approaches that can meet the needs of patients, clinicians and the wider community. We describe here an initiative that has borrowed concepts
Lauren Braun, Helena ML Daudt, Peter Watson   +2 more
doaj   +1 more source

AIFA Determination 809/2015 on Phase I Clinical Trials: a new challenge for Italian Research [PDF]

, 2016
Emanuela Marchesi, Manlio Monti, Sara Campora, G. Gentili, Paola Frati, S. Pirondi, C. Taverniti, Celeste Cagnazzo   +7 more
openalex   +1 more source

Long‐term outcome of dasatinib first‐line treatment in gastrointestinal stromal tumor: A multicenter, 2‐stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07) [PDF]

, 2018
Michael Montemurro, Angela Cioffi, Julien Dômont, Piotr Rutkowski, Arnaud Roth, Roger von Moos, Roman Inauen, Maud Toulmonde, Roger Burkhard, Claudio Knuesli, Sebastian Bauer, Philippe A. Cassier, Heike Schwarb, Axel Le Cesne, Dieter Koeberle, Daniela Bärtschi, Daniel Dietrich, Christine Biaggi, John O. Prior, Serge Leyvraz   +19 more
openalex   +1 more source

Landscape of clinical drug development of ADCs used for the pharmacotherapy of cancers: an overview of clinical trial registry data from 2002 to 2022

BMC Cancer
Background To provide reference for clinical development of ADCs in the industry, we analyzed the landscape and characteristics of clinical trials about antibody-drug conjugates (ADCs). Method Clinical trials to study ADCs used for the pharmacotherapy of
Wenjing Zhou, Zhiyuan Xu, Shu Liu, Xiaohuan Lou, Pengcheng Liu, Huali Xie, Shuiyan Zhang, Xi Liu, Baoshan Zhuo, Hongbing Huang   +9 more
doaj   +1 more source